Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Parkinsonism & Related Disorders

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2016.10.011PMID 27769648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease

  2015cited by this paper
• Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease

  2015cited by this paper
• Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease

  2015cited by this paper
• Diagnostic value of minor salivary glands biopsy for the detection of Lewy pathology.

  2013cited by this paper
• Submandibular gland biopsy for the diagnosis of Parkinson disease.

  2013cited by this paper
• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  2010cited by this paper
• Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease

  2010cited by this paper
• [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].

  2008cited by this paper
• Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.

  2008cited by this paper
• Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

  2008cited by this paper
• FP‐CIT and MIBG scintigraphy in early Parkinson's disease

  2005cited by this paper
• Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease

  2005cited by this paper
• Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT

  2004cited by this paper
• Lewy bodies in the sinoatrial nodal ganglion: Clinicopathological studies

  2004cited by this paper
• Autonomic dysfunction in Parkinson's disease

  2003cited by this paper
• Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific

  2000cited by this paper
• Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases

  1999cited by this paper
• Effect of specific activity on organ uptake of iodine-123-meta-iodobenzylguanidine in humans.

  1997cited by this paper
• Neuropathology of autonomic nervous system in Parkinson's disease.

  1997cited by this paper
• Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.

  1993cited by this paper
• Gastrointestinal dysfunction in Parkinson's disease

  1992cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes.

  1986cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• Esophageal Lewy bodies associated with ganglion cell loss in achalasia: Similarity to Parkinson's disease

  1984cited by this paper
• Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.

  1984cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Parkinsonism

  1967cited by this paper
• PATHOLOGY OF PARALYSIS AGITANS.

  1907cited by this paper

• Value of extra-cardiac sympathetic nervous uptake parameters based on 123I-MIBG SPECT/CT in the assessment of Parkinson’s disease

  2025cites this paper
• Value of multi-parameter 123I-MIBG scintigraphy in the differential diagnosis of Parkinson’s disease

  2025cites this paper
• Comparison of MIBG uptake in the major salivary glands between Lewy body disease and progressive supranuclear palsy

  2024cites this paper
• High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson’s disease

  2023cites this paper
• Reduced 123I-MIBG uptake in the parotid and submandibular glands in patients with Parkinson’s disease identified using a quantitative semi-automatic method

  2023cites this paper
• Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review

  2023cites this paper
• Analysis of heart rate response to obstructive apnea/hypopnea events in patients with Parkinson's disease with relatively severe sleep apnea syndrome

  2021cites this paper
• Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies

  2020cites this paper
• MIBG scintigraphy of the major salivary glands in progressive supranuclear palsy and corticobasal degeneration.

  2019cites this paper
• Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?

  2018cites this paper
• MIBG scintigraphy of the major salivary glands in multiple system atrophy.

  2018cites this paper